Home > Healthcare > Medical Devices > Therapeutic Devices > Xenotransplantation Market
Xenotransplantation Market size was valued at USD 12.7 billion in 2022 and is estimated to account for USD 29.9 billion by 2032. Xenotransplantation refers to the transplantation of living cells, tissues, or organs from one species to another, with the transplantation of animal (xenogeneic) organs or tissues into humans. It involves the transfer of biological material across species boundaries to replace or repair damaged or dysfunctional organs in recipients. The objective of xenotransplantation is to address the shortage of human organs available for transplantation by utilizing organs or tissues from non-human animal sources.
The rising demand for organ transplantation and the potential of xenotransplantation as a solution will create ample evolution opportunities to the business. For instance, as per the Global Observatory On Donation And Transplantation, more than 144,302 organ transplant procedures were performed in the year 2021. Among which kidney transplants registered highest share with 92,532 procedures worldwide. Moreover, high demand for organ transplants coupled with shortage of organ donors leads to long waiting times and high mortality rates.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Xenotransplantation Market Size in 2022: | USD 12.7 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8.9% |
2032 Value Projection: | USD 29.9 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 290 |
Tables, Charts & Figures: | 353 |
Segments covered: | Product Type, Application, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|